After-hours movers: Aurinia Pharma gains on possible sale, Nike falls on earnings

After-Hours Stock Movers:

Root Inc (NASDAQ:) 18% LOWER; says it is not in receipt of any proposal that is either actionable or in the best interests of shareholders

Accolade Inc (NASDAQ:) 17% HIGHER; reported Q1 EPS of ($0.52), $0.10 better than the analyst estimate of ($0.62). came in at $93.2 million versus the consensus estimate of $90.27M. Accolade sees Q2 2024 revenue of $93-95M, versus the consensus of $93M. Accolade sees FY2024 revenue of $410-414M, versus the consensus of $410M.

Aurinia Pharmaceuticals Inc. (NASDAQ:) 9% HIGHER; announced that its Board of Directors has initiated an exploration of strategic alternatives. As part of this process, the Board will consider a wide range of options for the company including, but not limited to, a potential sale, merger, or other strategic transaction.

Nike (NYSE:) 4% LOWER; reported Q4 EPS of $0.66, $0.02 worse than the analyst estimate of $0.68. came in at $12.8 billion versus the consensus estimate of $12.58B.